Mark Kaye - 02 Oct 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & CFO Designate
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 02 Oct 2023
Net transactions value: $0
Form type: 4
Filing time: 04 Oct 2023, 16:22:00 UTC
Previous filing: 06 Sep 2023
Next filing: 05 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Award	$0	+18,174		$0.000000	18,174	02 Oct 2023	Direct	F1
transaction	ELV	Common Stock	Award	$0	+2,102	+12%	$0.000000	20,276	02 Oct 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+8,076		$0.000000	8,076	02 Oct 2023	Common Stock	8,076	$440.19	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units. Restrictions lapse as follows: 6,058 shares each on 10/2/2024, 10/2/2025 and 10/2/2026.
F2	Represents restricted share units. Restrictions lapse as follows: 700 shares on 10/2/2024 and 701 shares each on 10/2/2025 and 10/2/2026.
F3	The option represents a right to purchase a total of 8,076 shares, and is exercisable in three annual installments of 2,692 shares each, beginning on 10/2/2024, which is the one-year anniversary of the option grant date.